Scientists Testing Inhaler Protection Against the Coronavirus

September 16, 2020

As the world waits for the development of an immunization to give people immunity against COVID-19, scientists at University of California in San Francisco are looking to test an aerosol which they believe can protect users from the coronavirus.

Users could self-administer the aerosol, dubbed “AeroNabs,” through a nasal spray or inhaler. Used once a day, it could provide protection against SARS-CoV-2 until a vaccine becomes available. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs, which they describe as “molecular personal protective equipment (PPE).”

The coronavirus invades hosts through its spikes. These spikes can switch from a closed, inactive state to an open, active state, during which it can attach to human cells that line the lung and airway. The aerosol works by disabling the spikes, thereby preventing the virus from infecting hosts.

Latest Articles

Optisolve
July 16, 2026 Sponsored by Optisolve

Protected: New Technology Platform Targets the Hidden 90% of Cleaning Budgets

July 15, 2026 Ronnie Phillips

Redefining the Restroom Experience Through Functional Modernization

July 13, 2026 Raquel Elejabarrieta

Rethink the Path to Leadership

Sponsored Articles

Optisolve
July 16, 2026 Sponsored by Optisolve

Protected: New Technology Platform Targets the Hidden 90% of Cleaning Budgets

July 7, 2026 Dr. Rebecca Bascom & Dr. Gavin Macgregor-Skinner & Dr. Omrana Pasha-Razzak

Evidence-Based Cleaning Ensures Healthy Places and Spaces

July 2, 2026

D.A.R.E. to Clean Restrooms Smarter with Tornado

Recent News

norovirus

Diarrhea Outbreak Expands

Legionnaires’ Disease Cases Grow in NYC

Most Americans Worried About Impact of Power Outages